Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis
<p><b>Background:</b> Integrase strand transfer inhibitor (INSTI) dolutegravir (DTG)-based antiretroviral therapy (ART) is recommended by World Health Organisation as preferred first-line regimen in pregnant women living with human immunodeficiency virus (HIV) (WLHIV). Non-nucleosi...
Auteurs principaux: | Beck, K, Cowdell, I, Portwood, C, Sexton, H, Kumarendran, M, Brandon, Z, Kirtley, S, Hemelaar, JH |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Frontiers Media
2024
|
Documents similaires
-
Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis
par: Katharina Beck, et autres
Publié: (2024-02-01) -
Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis
par: Cowdell, I, et autres
Publié: (2022) -
Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis
par: Imogen Cowdell, et autres
Publié: (2022-04-01) -
Adverse perinatal outcomes associated with antiretroviral therapy in women living with HIV: a systematic review and meta-analysis
par: Portwood, C, et autres
Publié: (2023) -
Association of nucleoside reverse transcriptase inhibitors with adverse perinatal outcomes in pregnant women living with HIV: systematic review and meta-analysis
par: Cowdell, I, et autres
Publié: (2025)